MedPath

FloSeal Tubeless Exit Versus Cope Loop Nephrostomy Versus Fascial Stitch Following Percutaneous Nephrolithotripsy

Not Applicable
Completed
Conditions
Kidney Calculi
Interventions
Procedure: Cope Loop
Procedure: Floseal
Procedure: Fascial Stitch
Registration Number
NCT00360477
Lead Sponsor
University of California, Irvine
Brief Summary

The patient will be asked to participate in a research project designed to determine the best way to prevent bleeding and promote patient comfort after having kidney stones removed. Two standard methods for ending the surgery are being compared to a newer method. In one standard method, the patient will have a tube draining urine from the kidney after the procedure. This tube may also prevent bleeding from the kidney. In another standard method the patient will have a tube left internally that drains urine from the kidney to the bladder and a stitch will be used to close the incision and deeper tissues in the back. In the third potential option, a tube would be left internally to drain urine from the kidney to the patient's bladder and the surgical site would be filled with a clot promoting agent (FloSeal) which is a FDA approved agent specifically formulated to stop bleeding during surgical procedures.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • The patient has kidney stones that require treatment (tx) with percutaneous stone removal
  • 18 years of age or over
Exclusion Criteria
  • Patient mentally impaired, have a chronic pain syndrome or disorder, or any condition that might alter the sensation of pain
  • Patient taking coumadin
  • Pre-existing percutaneous nephrostomy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2Cope LoopCope-Loop/Nephrostomy Tube
1FlosealFloseal
3Fascial StitchFascial Stitch
Primary Outcome Measures
NameTimeMethod
To determine which method of treatment causes the least pain to the patient.one month
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of California, Irvine Medical Center-Department of Urology

🇺🇸

Orange, California, United States

© Copyright 2025. All Rights Reserved by MedPath